ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0145

Community Mobility in a Diverse Cohort of Individuals with Systemic Lupus Erythematosus

Leila Milanfar1, Jinoos Yazdany2, Amanda Eudy3, Courtney Hoge4, Charmayne M. Dunlop-Thomas5, Patti Katz6 and Laura Plantinga7, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Duke University, Raleigh, NC, 4Emory University, Atlanta, GA, 5Emory University School of Medicine, Department of Medicine, Division of Rheumatology, Atlanta, GA, 6UCSF, San Rafael, CA, 7University of California, San Francisco, San Francisco, CA

Meeting: ACR Convergence 2024

Keywords: Aging, Epidemiology, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Measurement of the extent to which individuals move throughout their community and participate in social activities (“community mobility”) can provide a snapshot of how the effects of aging, disease, and other factors may restrict patients’ daily lives. Despite the clear relevance and benefits of community mobility, to our knowledge, it has never been measured in the setting of SLE. We used a novel measure, Life Space Assessment (LSA), to characterize and identify potential correlates of community mobility among a population-based, primarily Black U.S. cohort of individuals with SLE.

Methods: Participants meeting a validated definition of SLE were recruited for a one-time study visit (10/2019-5/2022) from the ongoing Georgians Organized Against Lupus (GOAL) cohort. Community mobility was measured via the University of Alabama at Birmingham LSA, which asks participants to report how far and how often they have traveled to life-space “levels” and how much help they needed to reach the levels (Table 1). The overall LSA score ranges from 0 to 120, with higher scores representing greater and more independent community mobility. We used descriptive statistics to report the LSA score distribution and assess the percentages of participants reaching each life-space level and multivariable logistic regression to assess the adjusted percentages reaching the neighborhood level without assistance by sociodemographic (age, sex, race, education, income) and clinical (self-reported disease activity, cumulative disease damage, and steroid use) factors, with adjustment for all other variables. 

Results: Substantial restrictions in community mobility and, potentially, social participation were common in this SLE cohort, with nearly half of participants not traveling out of their neighborhood at least weekly without assistance. Further, the mean score in our cohort falls below the means reported in older adults and those with chronic obstructive pulmonary disease and chronic kidney disease. We found that better community mobility may be associated with higher socioeconomic indicators and lower SLE activity, but not with age or sex. Characterizing community mobility in individuals with SLE is a first step toward supporting evidence-based strategies for mitigating restrictions in life participation in this population.

Conclusion: Substantial restrictions in community mobility and social participation may be common in SLE, with nearly half of participants not traveling out of their neighborhood at least weekly without assistance. Further, the mean score in our cohort falls below means reported in older adults and those with chronic obstructive pulmonary disease and chronic kidney disease. We found that better community mobility and social participation may be associated with higher socioeconomic indicators and lower SLE activity, but not with age or sex. Characterizing community mobility in individuals with SLE is a first step toward supporting evidence-based strategies for mitigating restrictions in life participation among these patients.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: L. Milanfar: None; J. Yazdany: AstraZeneca, 2, Aurinia, 5, Bristol-Myers Squibb(BMS), 2, UCB, 2; A. Eudy: Exagen, 5, GlaxoSmithKline, 5, Immunovant, 5; C. Hoge: None; C. Dunlop-Thomas: None; P. Katz: None; L. Plantinga: None.

To cite this abstract in AMA style:

Milanfar L, Yazdany J, Eudy A, Hoge C, Dunlop-Thomas C, Katz P, Plantinga L. Community Mobility in a Diverse Cohort of Individuals with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/community-mobility-in-a-diverse-cohort-of-individuals-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/community-mobility-in-a-diverse-cohort-of-individuals-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology